These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8448714)

  • 1. Changes in appetite and weight during the pharmacological treatment of patients with panic disorder.
    Balon R; Yeragani VK; Pohl R; Merlos B; Sherwood P
    Can J Psychiatry; 1993 Feb; 38(1):19-22. PubMed ID: 8448714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate-induced anxiety after imipramine and diazepam treatment.
    Pohl R; Balon R; Berchou R; Lycaki H
    Anxiety; 1994; 1(2):54-63. PubMed ID: 9160549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changes of thyroid hormone during pharmacological treatment of panic disorder patients.
    Balon R; Pohl R; Yeragani VK; Ramesh C; Glitz DA
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):595-600. PubMed ID: 1956988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
    Modigh K; Westberg P; Eriksson E
    J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
    Mavissakalian M; Perel JM
    Arch Gen Psychiatry; 1992 Apr; 49(4):318-23. PubMed ID: 1558466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.
    Uhlenhuth EH; Matuzas W; Warner TD; Paine S; Lydiard RB; Pollack MH
    J Clin Psychopharmacol; 2000 Dec; 20(6):622-7. PubMed ID: 11106133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of panic disorder.
    Cassano GB; Toni C; Musetti L
    Adv Biochem Psychopharmacol; 1992; 47():449-60. PubMed ID: 1509926
    [No Abstract]   [Full Text] [Related]  

  • 10. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR; Perel JM
    Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C
    Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific side effects of long-term imipramine management of panic disorder.
    Mavissakalian M; Perel J; Guo S
    J Clin Psychopharmacol; 2002 Apr; 22(2):155-61. PubMed ID: 11910260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appetite and food preference in depression: effects of imipramine treatment.
    Fernstrom MH; Krowinski RL; Kupfer DJ
    Biol Psychiatry; 1987 May; 22(5):529-39. PubMed ID: 3580430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia.
    Mavissakalian M; Perel JM
    Am J Psychiatry; 1992 Aug; 149(8):1053-7. PubMed ID: 1636805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up.
    Albus M; Scheibe G; Scherer J
    J Affect Disord; 1995 May; 34(2):109-15. PubMed ID: 7665802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance drug therapy of panic disorder.
    Curtis GC; Massana J; Udina C; Ayuso JL; Cassano GB; Perugi G
    J Psychiatr Res; 1993; 27 Suppl 1():127-42. PubMed ID: 8145175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.
    Br J Psychiatry; 1992 Feb; 160():191-202; discussion 202-5. PubMed ID: 1540759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo.
    Cassano GB; Toni C; Petracca A; Deltito J; Benkert O; Curtis G; Hippius H; Maier W; Shera D; Klerman G
    Eur Neuropsychopharmacol; 1994 Mar; 4(1):47-53. PubMed ID: 8204996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.